Background/aim: As the number of case reports related to the new type of coronavirus (COVID-19) increases, knowledge of and experience with the virus and its complications also increase. Pleural complications are one relevant issue. We aimed in this study to analyze pleural complications, such as pneumothorax, pneumomediastinum, and empyema, in patients hospitalized with the diagnosis of COVID-19 pneumonia. Materials and methods: The files of patients who have pleural complications of COVID-19 pneumonia and were consulted about thoracic surgery between March 2020 and December 2020 were retrospectively reviewed. The data of the patients were analyzed according to age, sex, length of stay, treatment method for pleural complications, mortality, severity of COVID-19 pneumonia, tube thoracostomy duration, and presence of a mechanical ventilator. Results: A total of 31 patients fulfilling the inclusion criteria were included in the study. There were 11 female (35.5%) and 20 male (65.5%) patients. The most common complication was pneumothorax in 20 patients (65%). The median duration of hospitalization was 22 days and the mortality rate was 71%. Mortality was significantly higher in patients on mechanical ventilation (p = 0.04). Conclusion: The mortality rate is very high in patients with pleural complications of COVID-19 pneumonia. Pneumothorax is a fatal complication in critically ill patients with COVID-19 pneumonia.
Pneumothorax, pneumomediastinum, COVID-19, empyema, pandemic
TÜRK, MERVE ŞATIR; AKARSU, IRMAK; TOMBUL, İSMAİL; KANKOÇ, AYKUT; ÖZKAN, NUR DİLVİN; VALIYEV, ELGUN; SAYAN, MUHAMMET; ÇELİK, ALİ; KURUL, İSMAİL CÜNEYT; ARIBAŞ, OLGUN KADİR; and TAŞTEPE, ABDULLAH İRFAN
"The analysis of pleural complications of COVID-19 pneumonia,"
Turkish Journal of Medical Sciences: Vol. 51:
6, Article 3.
Available at: https://journals.tubitak.gov.tr/medical/vol51/iss6/3